dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:21:54Z
dc.date.available2014-05-27T11:21:54Z
dc.date.created2014-05-27T11:21:54Z
dc.date.issued2006-07-01
dc.identifierBrazilian Oral Research, v. 20, n. 3, p. 196-201, 2006.
dc.identifier1806-8324
dc.identifier1807-3107
dc.identifierhttp://hdl.handle.net/11449/68959
dc.identifier10.1590/S1806-83242006000300003
dc.identifierS1806-83242006000300003
dc.identifier2-s2.0-33750352951
dc.identifier2-s2.0-33750352951.pdf
dc.identifier0190365234516027
dc.description.abstractOsteoporosis, a disease characterized by progressive bone loss, has been the target of several studies in the past few years. It results in a much higher risk for fractures and might cause slower bone lesion healing. The aim of this work was to study the effects of Risedronate (allopathic medicine) and Calcarea phosphorica 6CH (homeopathic medicine) on the repair of bone lesions in male rats with osteoporosis induced by castration. Eighty-four three-month-old rats were used divided into four groups of twenty-one animals each. Three groups where castrated and one group was submitted to Sham surgery. One month later, cortical lesions were made in all animals' tibiae and, after one day, the different experimental treatments began according to the following groups: CR - castrated/Risedronate (1 mg/kg/day); CCp - castrated/ Calcarea phosphorica 6CH (3 drops/day); CP - castrated/placebo and SP - Sham/placebo. The animals were sacrificed at seven, fourteen and twenty-eight days after the beginning of the treatments and had their tibiae removed. Digital radiographs of the tibiae were taken and analyzed in order to evaluate the optical density of the defect area. Then, they were decalcified and processed for histological and histomorphometrical analysis. The data were submitted to ANOVA, and to the Tukey and Dunnett tests (5%). The allopathic and homeopathic treatments led to different bone formation as regards remodeling and maturation aspects. Further research is necessary to access the resistance and quality of the newly formed bone.
dc.languageeng
dc.relationBrazilian Oral Research
dc.relation1.223
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectAllopathy
dc.subjectCalcarea phosphorica
dc.subjectFracture healing
dc.subjectHomeopathy
dc.subjectbone density conservation agent
dc.subjectcalcium phosphate
dc.subjectdrug derivative
dc.subjectetidronic acid
dc.subjectplant medicinal product
dc.subjectrisedronic acid
dc.subjectanalysis of variance
dc.subjectanimal
dc.subjectbone density
dc.subjectbone remodeling
dc.subjectdisease model
dc.subjectdrug effect
dc.subjectmale
dc.subjectorchiectomy
dc.subjectosteoporosis
dc.subjectpathology
dc.subjectphytotherapy
dc.subjectrat
dc.subjectAnalysis of Variance
dc.subjectAnimals
dc.subjectBone Density
dc.subjectBone Density Conservation Agents
dc.subjectBone Remodeling
dc.subjectCalcium Phosphates
dc.subjectDisease Models, Animal
dc.subjectEtidronic Acid
dc.subjectMale
dc.subjectOrchiectomy
dc.subjectOsteoporosis
dc.subjectPhytotherapy
dc.subjectPlant Preparations
dc.subjectRats
dc.titleComparative therapeutic use of Risedronate and Calcarea phosphorica - Allopathy versus homeopathy - In bone repair in castrated rats
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución